Ross Haghighat resigns as Chair of Sernova Biotherapeutics (SEOVF), effective May 24, 2025. Sernova is pioneering the development of a Cell Pouch Bio-hy
LONDON, Ontario and BOSTON, May 26, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) ( SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine co
LONDON, Ontario and BOSTON, May 22, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) ( SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine co
LONDON, Ontario and BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) ( SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine
LONDON, Ontario and BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) ( SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine c
LONDON, Ontario and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) ( SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focu
Signed Letter of Intent with ”˜Project REEM Ventures' for Product Development and Commercialization in the Kingdom of Saudi Arabia Renowned Diabetes Expert Dr
Toronto-based software startup Cardata is among the latest to join the wave of Canadian tech leadership turnover, appointing Haywood Marsh as its new CEO.
Dr. Alice Tomei of the University of Miami, Miller School of Medicine, to present updates in podium presentation at the 2023 IPITA-IXA-CTRMS Joint Congress...
Issuer: Sernova Corp.
/ Key word: Conference/Research Update
Sernova to Present at 2023 Alliance for Regenerative Medicine Cell & Gene Meeting on the Med
10.04.2023 / 13:05... | April 10, 2023
ABSTRACT OF SERNOVA'S COLLABORATION WITH EVOTEC ON IPSC AND CELL POUCH™ COMBINATION TREATMENT DATA FOR TYPE ONE DIABETES SELECTED FOR ORAL PODIUM PRESENTATION
... | March 14, 2023